Lumenis introduces OptiLight at Vision Expo West


The new intense pulsed light technology targets meibomian gland dysfunction

An intense pulsed light device is being used near a patient's eyes

Lumenis launched its OptiLight intense pulsed light (IPL) device at Vision Expo West 2021 in Las Vegas, Nevada.

The FDA granted the company authorization for OptiLight, which is designed to improve dry eye disease through the use of IPL.

Study results

A multicenter, double-blinded, randomized controlled trial revealed that the Lumenis IPL system with Optimal Pulse Technology (OPT) significantly improved tear break-up time, meibum quality, and meibomian gland expressibility.1

Related: Optimizing management of dry eye disease

“Unless we address the underlying inflammation, it’s difficult to meaningfully impact dry eye disease,” said Steven J. Dell, lead investigator in the clinical trial, in a statement.1 “OptiLight helps us to address the inflammation, and improves signs of dry eye disease due to MGD, positioning it as a valuable tool in our dry eye toolkit.”

Related news

In related news, private equity firm Baring Private Equity Asia and Lumenis have partnered to accelerate the investment in vision and aesthetics vertical markets following the sale of Lumenis Surgical for $1.07B.

Lumenis recently completed the sale of its surgical division to Boston Scientific Corporation, a global medical device manufacturer.2

The company plans to increase its vision and aesthetic businesses through its research, development, and marketing efforts.2

Related: How to implement IPL into an optometry practice


1. Britton G. Lumenis receives FDA approval for Its IPL device to manage dry eye disease and launches OptiLight. Lumenis news release. April 29, 2021. Accessed September 22, 2021.

2. Lumenis and Baring Private Equity Asia to accelerate investment in aesthetics and vision verticals following the strategic sale of Lumenis Surgical for $1.07B. Lumenis news release. September 1, 2021. Accessed September 22, 2021.

Related Videos
A. Philip Aitsebaomo, O.D., Ph.D. outlines his talk on treating patients with prosthetic eyes
Mandy Sallach of Johnson & Johnson speaks on initiatives to combat pediatric myopia
Spencer Johnson, OD, FAAO, overviews his talk on laser procedures at Optometry's Meeting
Dr Clark Chang overviews how to fit wavefront guided contact lenses at Optometry's Meeting
Ruth Shoge, OD, MPH, FAAO, details a lecture she gave on ACES at Optometry's Meeting
Drs Tracy Schroeder Swartz and Clark Chang overview their keratoconus talk at Optometry's Meeting
Tracy Lynn Schroeder Swartz O.D., M.S., FAAO, overviews her talk on comanagement
Christi Closson, OD, FAAO, details fitting contact lenses for astigmatism and other products by Johnson and Johnson
Drs Erin Draper and Chris Cuk outline the important role optometrists have in spotting neurodegenerative disease in patients
© 2024 MJH Life Sciences

All rights reserved.